<p id="thickbox_headline">Bayer AG has asked California's Supreme Court to review a decision awarding $20.5 million to a groundskeeper who claimed the company's Roundup weedkiller caused his cancer, arguing the ruling was at odds with federal law and settled legal principles.</p>.<p>Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, said the July decision by the California Court of Appeal affirming a 2018 jury verdict in favor of Dewayne Johnson would be relied upon by other courts handling cases over the widely used herbicide.</p>.<p>A San Francisco jury initially awarded Johnson $289.2 million after finding the chemical glyphosate in Roundup caused his non-Hodgkin's lymphoma.</p>.<p>The trial judge reduced that amount to $78.5 million and the Court of Appeal reduced that to $20.5 million.</p>.<p>"In this case, the Court of Appeal affirmed a verdict that severely punishes Monsanto for complying with federal law,” said the petition by the company, which has long said regulators have deemed glyphosate safe for use by humans.</p>.<p>Bayer said the high court should determine if a manufacturer of a federally approved herbicide can be liable under state law for failing to provide a cancer warning when the federal regulator determined federal law does not permit that warning.</p>.<p>Johnson also asked for a review of the Court of Appeal ruling reducing the damages.</p>.<p>He said the Supreme Court of California should decide if "loss of enjoyment of life" damages should include compensation for a shortened life expectancy caused by the wrongful act of the defendant.</p>.<p>Johnson's case is separate from Bayer's agreement on June 24 to pay up to $10.9 billion to settle nearly 100,000 lawsuits in the United States claiming that Roundup caused cancer.</p>.<p>If upheld, the verdict and payout could make it harder for Bayer to resolve lawsuits by other plaintiffs.</p>
<p id="thickbox_headline">Bayer AG has asked California's Supreme Court to review a decision awarding $20.5 million to a groundskeeper who claimed the company's Roundup weedkiller caused his cancer, arguing the ruling was at odds with federal law and settled legal principles.</p>.<p>Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, said the July decision by the California Court of Appeal affirming a 2018 jury verdict in favor of Dewayne Johnson would be relied upon by other courts handling cases over the widely used herbicide.</p>.<p>A San Francisco jury initially awarded Johnson $289.2 million after finding the chemical glyphosate in Roundup caused his non-Hodgkin's lymphoma.</p>.<p>The trial judge reduced that amount to $78.5 million and the Court of Appeal reduced that to $20.5 million.</p>.<p>"In this case, the Court of Appeal affirmed a verdict that severely punishes Monsanto for complying with federal law,” said the petition by the company, which has long said regulators have deemed glyphosate safe for use by humans.</p>.<p>Bayer said the high court should determine if a manufacturer of a federally approved herbicide can be liable under state law for failing to provide a cancer warning when the federal regulator determined federal law does not permit that warning.</p>.<p>Johnson also asked for a review of the Court of Appeal ruling reducing the damages.</p>.<p>He said the Supreme Court of California should decide if "loss of enjoyment of life" damages should include compensation for a shortened life expectancy caused by the wrongful act of the defendant.</p>.<p>Johnson's case is separate from Bayer's agreement on June 24 to pay up to $10.9 billion to settle nearly 100,000 lawsuits in the United States claiming that Roundup caused cancer.</p>.<p>If upheld, the verdict and payout could make it harder for Bayer to resolve lawsuits by other plaintiffs.</p>